These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24127941)

  • 1. Public health genomics and personalized prevention: lessons from the COGS project.
    Pashayan N; Hall A; Chowdhury S; Dent T; Pharoah PD; Burton H
    J Intern Med; 2013 Nov; 274(5):451-6. PubMed ID: 24127941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence for expanded genetic testing for pediatric patients with cancer.
    Maese L; Schiffman JD
    Future Oncol; 2018 Feb; 14(3):187-190. PubMed ID: 29327612
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
    Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
    CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can polygenic inheritance be used in population screening for common diseases?
    Khoury MJ; Janssens AC; Ransohoff DF
    Genet Med; 2013 Jun; 15(6):437-43. PubMed ID: 23412608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
    Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics for disease treatment and prevention.
    Bloss CS; Jeste DV; Schork NJ
    Psychiatr Clin North Am; 2011 Mar; 34(1):147-66. PubMed ID: 21333845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genomics for personalized cancer therapy.
    Tyner JW
    Sci Transl Med; 2014 Jul; 6(243):243fs26. PubMed ID: 24990879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
    Hall AE; Chowdhury S; Pashayan N; Hallowell N; Pharoah P; Burton H
    J Med Ethics; 2014 Mar; 40(3):163-7. PubMed ID: 23454719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based Genetic Testing for Precision Prevention.
    Evans O; Manchanda R
    Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine: Changing the way we think about healthcare.
    Gameiro GR; Sinkunas V; Liguori GR; Auler-Júnior JOC
    Clinics (Sao Paulo); 2018 Dec; 73():e723. PubMed ID: 30517307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomics: what it is and why it is important.
    Mazurowski MA
    J Am Coll Radiol; 2015 Aug; 12(8):862-6. PubMed ID: 26250979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating genomics into breast and prostate cancer screening: assessing the implications.
    Chowdhury S; Dent T; Pashayan N; Hall A; Lyratzopoulos G; Hallowell N; Hall P; Pharoah P; Burton H
    Genet Med; 2013 Jun; 15(6):423-32. PubMed ID: 23412607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.
    Hall AE; Chowdhury S; Hallowell N; Pashayan N; Dent T; Pharoah P; Burton H
    J Public Health (Oxf); 2014 Jun; 36(2):285-91. PubMed ID: 23986542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
    Knapp E
    J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a personalized medicine infrastructure at a major cancer center.
    Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
    J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
    Schee Genannt Halfmann S; Evangelatos N; Schröder-Bäck P; Brand A
    Per Med; 2017 Jan; 14(1):63-74. PubMed ID: 29749826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.